Scarica l'app Stockscreener
49.82
4.12%
-2.14
Dopo l'orario di chiusura:
49.82
Rhythm Pharmaceuticals Inc Borsa (RYTM) Ultime notizie
Corebridge Financial Inc. Has $1.52 Million Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
(RYTM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $69.46 Average Target Price from Analysts - Defense World
Teacher Retirement System of Texas Increases Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - The AM Reporter
When Will Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Breakeven? - simplywall.st
Teacher Retirement System of Texas Has $761,000 Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Rhythm Pharma ends RareStone licensing deal in China - MSN
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Equities Analysts Offer Predictions for RYTM Q1 Earnings - Defense World
Q2 Earnings Estimate for RYTM Issued By HC Wainwright - Defense World
Swiss National Bank Has $5.05 Million Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given Buy Rating at HC Wainwright - Defense World
Rhythm Pharmaceuticals corporate controller sells shares for $18,655 By Investing.com - Investing.com Australia
Rhythm Pharmaceuticals corporate controller sells shares for $18,655 - Investing.com India
Analyst Expectations For Rhythm Pharmaceuticals's Future - Benzinga
Is Rhythm Pharmaceuticals (RYTM) a Worst High-Risk High-Reward Growth Stock to Buy? - MSN
(RYTM) Proactive Strategies - news.stocktradersdaily.com
Rhythm Pharma stock down as licensing deal ends (RYTM:NASDAQ) - Seeking Alpha
Victory Capital Management Inc. Reduces Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals regains rights to obesity drug in China By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - MarketScreener
Rhythm Pharmaceuticals regains rights to obesity drug in China - Investing.com India
Rhythm Pharmaceuticals Reacquires Licensing Rights to - GlobeNewswire
Strategic Win: Rhythm Pharmaceuticals Reclaims IMCIVREE Rights in China, Strengthens Global Position - StockTitan
Rhythm Pharmaceuticals Announces Orphan Drug Designation - GlobeNewswire
Rhythm Pharmaceuticals receives orphan drug status in Japan By Investing.com - Investing.com Australia
Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted To Setmelanotide For Treatment Of Hypothalamic Obesity In Japan - Marketscreener.com
Rhythm Pharmaceuticals receives orphan drug status in Japan - Investing.com
Rhythm Pharmaceuticals Receives Orphan-Drug Designation in Japan for Obesity Treatment - MarketWatch
Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan - The Manila Times
Breakthrough for Rare Obesity: Rhythm's Drug Wins Special Status in Japan - StockTitan
Rhythm Pharmaceuticals EVP sells shares worth $3.86 million By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Has $24.65 Million Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $66.00 Price Target at Needham & Company LLC - Defense World
Rhythm Pharmaceuticals EVP sells shares worth $3.86 million - Investing.com India
Needham raises Rhythm Pharma stock target to $66, maintains buy By Investing.com - Investing.com UK
Rhythm Pharmaceuticals and Raymond A. Wood Foundation Launch Research Collaboration on Fatigue in Craniopharyngioma Patients - Nasdaq
Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration - GlobeNewswire
Bank of New York Mellon Corp Sells 680 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Insider Sell Alert: EVP, Head of North America Jennifer Lee Sells Shares of Rhythm Pharmaceuticals Inc (RYTM) - GuruFocus.com
How To Trade (RYTM) - Stock Traders Daily
SBI Securities Co. Ltd. Invests $37,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World
Stifel maintains Buy on Rhythm Pharmaceuticals, $78 target By Investing.com - Investing.com Canada
Stifel maintains Buy on Rhythm Pharmaceuticals, $78 target - Investing.com India
Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):